These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 11726333
1. Substance abuse in the workplace: epidemiology, effects, and industry response. Bush DM, Autry JH. Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333 [Abstract] [Full Text] [Related]
2. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers]. Magnavita N, Bergamaschi A, Chiarotti M, Colombi A, Deidda B, De Lorenzo G, Goggiamani A, Magnavita G, Ricciardi W, Sacco A, Spagnolo AG, Bevilacqua L, Brunati MM, Campanile T, Cappai M, Cicerone M, Ciprani F, Di Giannantonio M, Di Martino G, Fenudi L, Garbarino S, Lopez A, Mammi F, Orsini D, Ranalletta D, Simonazzi S, Stanzani C. Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471 [Abstract] [Full Text] [Related]
3. Substance abuse and the uninsured worker in the United States. Galvin DM, Miller TR, Spicer RS, Waehrer GM. J Public Health Policy; 2007; 28(1):102-17. PubMed ID: 17363941 [Abstract] [Full Text] [Related]
4. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing. Miller TR, Zaloshnja E, Spicer RS. Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723 [Abstract] [Full Text] [Related]
5. Administrative issues related to addiction in the workplace. Roberts S, Fallon LF. Occup Med; 2001 May; 16(3):509-15, v. PubMed ID: 11401795 [Abstract] [Full Text] [Related]
6. Chemical dependency and drug testing in the workplace. Osterloh JD, Becker CE. West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418 [Abstract] [Full Text] [Related]
7. Drug-free workplace programmes: New Zealand perspective. Nolan S. Forensic Sci Int; 2008 Jan 30; 174(2-3):125-32. PubMed ID: 17467938 [Abstract] [Full Text] [Related]
8. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Bush DM. Forensic Sci Int; 2008 Jan 30; 174(2-3):111-9. PubMed ID: 17434274 [Abstract] [Full Text] [Related]
9. Comprehensive drug-abuse program can prove effective in the workplace. Marini GA. Occup Health Saf; 1991 Apr 30; 60(4):54, 56, 58-9. PubMed ID: 2052276 [No Abstract] [Full Text] [Related]
10. Legal issues facing physicians: substance abuse in the workplace. Clark HW, Johnson B. Occup Med; 2002 Apr 30; 17(1):119-35, v. PubMed ID: 11726341 [Abstract] [Full Text] [Related]
11. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser; 1993 Apr 30; 833():1-34. PubMed ID: 8367980 [No Abstract] [Full Text] [Related]
12. Drugs and alcohol in the workplace. Conry PB. AAOHN J; 1991 Oct 30; 39(10):461-5. PubMed ID: 1930379 [Abstract] [Full Text] [Related]
13. The relationship between employer health insurance characteristics and the provision of employee assistance programs. Zarkin GA, Garfinkel SA. Inquiry; 1994 Oct 30; 31(1):102-14. PubMed ID: 8168905 [Abstract] [Full Text] [Related]
14. Current practice and experience in drug and alcohol testing in the workplace. Zwerling C. Bull Narc; 1993 Oct 30; 45(2):155-96. PubMed ID: 7920540 [Abstract] [Full Text] [Related]
15. Workplace drug testing and worker drug use. Carpenter CS. Health Serv Res; 2007 Apr 30; 42(2):795-810. PubMed ID: 17362218 [Abstract] [Full Text] [Related]
16. The synergism of health promotion and restoration in the prevention of substance abuse in the workplace. Miller RE, Shain M, Crim D, Golaszewski TJ. Health Values; 1985 Apr 30; 9(5):50-8. PubMed ID: 10317664 [Abstract] [Full Text] [Related]
17. The role of the occupational physician in substance abuse. Lambert SD. Occup Med; 2002 Apr 30; 17(1):1-12, iii. PubMed ID: 11726332 [Abstract] [Full Text] [Related]
18. Drugs in the workplace. Rhodes D. Occup Health Saf; 1998 Oct 30; 67(10):136-8. PubMed ID: 9772758 [No Abstract] [Full Text] [Related]
19. Prevalence and consequences of smoking, alcohol use, and illicit drug use at five worksites. French MT, Zarkin GA, Hartwell TD, Bray JW. Public Health Rep; 1995 Oct 30; 110(5):593-9. PubMed ID: 7480614 [Abstract] [Full Text] [Related]
20. Do we have the training? The ethics of workplace drug testing and the GP. Evans A, Thornett A. Aust Fam Physician; 2003 Aug 30; 32(8):645-7. PubMed ID: 12973876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]